-
1
-
-
0004280239
-
-
K. Rother, G.G. Till Eds, Springer, ISBN 3-540-18205-5
-
K. Rother, G.G. Till (Eds.), The Complement System, Springer, 1988. ISBN 3-540-18205-5.
-
(1988)
The Complement System
-
-
-
2
-
-
0017356973
-
The role of membrane receptors for C3b and C3d in phagocytosis
-
Ehlenberger A.G., and Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J. Exp. Med. 145 (1977) 357-371
-
(1977)
J. Exp. Med.
, vol.145
, pp. 357-371
-
-
Ehlenberger, A.G.1
Nussenzweig, V.2
-
3
-
-
0018377605
-
Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins
-
Podack E.R., Biesecker G., and Muller-Eberhard H.J. Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins. Proc. Natl. Acad. Sci. USA 76 (1979) 897-901
-
(1979)
Proc. Natl. Acad. Sci. USA
, vol.76
, pp. 897-901
-
-
Podack, E.R.1
Biesecker, G.2
Muller-Eberhard, H.J.3
-
4
-
-
0021713655
-
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
-
Medof M.E., Kinoshita T., and Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med. 160 (1984) 1558-1578
-
(1984)
J. Exp. Med.
, vol.160
, pp. 1558-1578
-
-
Medof, M.E.1
Kinoshita, T.2
Nussenzweig, V.3
-
5
-
-
0022517078
-
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b
-
Seya T., Turner J.R., and Atkinson J.P. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163 (1986) 837-855
-
(1986)
J. Exp. Med.
, vol.163
, pp. 837-855
-
-
Seya, T.1
Turner, J.R.2
Atkinson, J.P.3
-
6
-
-
0024234820
-
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis
-
Klickstein L.B., Bartow T.J., Miletic V., Rabson L.D., Smith J.A., and Fearon D.T. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168 (1988) 1699-1717
-
(1988)
J. Exp. Med.
, vol.168
, pp. 1699-1717
-
-
Klickstein, L.B.1
Bartow, T.J.2
Miletic, V.3
Rabson, L.D.4
Smith, J.A.5
Fearon, D.T.6
-
7
-
-
0023604649
-
Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes
-
Zalman L.S., Wood L.M., and Muller-Eberhard H.J. Inhibition of antibody-dependent lymphocyte cytotoxicity by homologous restriction factor incorporated into target cell membranes. J. Exp. Med. 166 (1987) 947-955
-
(1987)
J. Exp. Med.
, vol.166
, pp. 947-955
-
-
Zalman, L.S.1
Wood, L.M.2
Muller-Eberhard, H.J.3
-
8
-
-
0035094143
-
Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases
-
Miwa T., and Song W.C. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int. Immunopharmacol. 1 (2001) 445-459
-
(2001)
Int. Immunopharmacol.
, vol.1
, pp. 445-459
-
-
Miwa, T.1
Song, W.C.2
-
9
-
-
0028954469
-
Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein
-
Kim Y.U., Kinoshita T., Molina H., Hourcade D., Seya T., Wagner L.M., and Holers V.M. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181 (1995) 151-159
-
(1995)
J. Exp. Med.
, vol.181
, pp. 151-159
-
-
Kim, Y.U.1
Kinoshita, T.2
Molina, H.3
Hourcade, D.4
Seya, T.5
Wagner, L.M.6
Holers, V.M.7
-
10
-
-
0032520024
-
Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells
-
Tsujimura A., Shida K., Kitamura M., Nomura M., Takeda J., Tanaka H., Matsumoto M., Matsumiya K., Okuyama A., Nishimune Y., Okabe M., and Seya T. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem. J. 330 Pt. 1 (1998) 163-168
-
(1998)
Biochem. J.
, vol.330
, Issue.PART 1
, pp. 163-168
-
-
Tsujimura, A.1
Shida, K.2
Kitamura, M.3
Nomura, M.4
Takeda, J.5
Tanaka, H.6
Matsumoto, M.7
Matsumiya, K.8
Okuyama, A.9
Nishimune, Y.10
Okabe, M.11
Seya, T.12
-
11
-
-
0034776676
-
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies
-
Lin F., Fukuoka Y., Spicer A., Ohta R., Okada N., Harris C.L., Emancipator S.N., and Medof M.E. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104 (2001) 215-225
-
(2001)
Immunology
, vol.104
, pp. 215-225
-
-
Lin, F.1
Fukuoka, Y.2
Spicer, A.3
Ohta, R.4
Okada, N.5
Harris, C.L.6
Emancipator, S.N.7
Medof, M.E.8
-
12
-
-
0034695647
-
A critical role for murine complement regulator Crry in fetomaternal tolerance
-
Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., and Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 287 (2000) 498-501
-
(2000)
Science
, vol.287
, pp. 498-501
-
-
Xu, C.1
Mao, D.2
Holers, V.M.3
Palanca, B.4
Cheng, A.M.5
Molina, H.6
-
14
-
-
34248679904
-
+ regulatory T cells in transplantation: progress, challenges and prospects
-
+ regulatory T cells in transplantation: progress, challenges and prospects. Am. J. Transplant. 7 (2007) 1457-1463
-
(2007)
Am. J. Transplant.
, vol.7
, pp. 1457-1463
-
-
Kang, S.M.1
Tang, Q.2
Bluestone, J.A.3
-
15
-
-
0035880233
-
Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria
-
Holt D.S., Botto M., Bygrave A.E., Hanna S.M., Walport M.J., and Morgan B.P. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98 (2001) 442-449
-
(2001)
Blood
, vol.98
, pp. 442-449
-
-
Holt, D.S.1
Botto, M.2
Bygrave, A.E.3
Hanna, S.M.4
Walport, M.J.5
Morgan, B.P.6
-
16
-
-
0033022585
-
Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells
-
Spiller O.B., Harris C.L., and Morgan B.P. Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells. J. Immunol. Methods 224 (1999) 51-60
-
(1999)
J. Immunol. Methods
, vol.224
, pp. 51-60
-
-
Spiller, O.B.1
Harris, C.L.2
Morgan, B.P.3
-
17
-
-
0028946568
-
Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis
-
Quigg R.J., Holers V.M., Morgan B.P., and Sneed III A.E. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J. Immunol. 154 (1995) 3437-3443
-
(1995)
J. Immunol.
, vol.154
, pp. 3437-3443
-
-
Quigg, R.J.1
Holers, V.M.2
Morgan, B.P.3
Sneed III, A.E.4
-
18
-
-
0024566684
-
Decay accelerating factor regulates complement activation on glomerular epithelial cells
-
Quigg R.J., Nicholson-Weller A., Cybulsky A.V., Badalamenti J., and Salant D.J. Decay accelerating factor regulates complement activation on glomerular epithelial cells. J. Immunol. 142 (1989) 877-882
-
(1989)
J. Immunol.
, vol.142
, pp. 877-882
-
-
Quigg, R.J.1
Nicholson-Weller, A.2
Cybulsky, A.V.3
Badalamenti, J.4
Salant, D.J.5
-
20
-
-
0020974261
-
Role of the complement receptor CR1 in the processing of substrate-bound C3
-
Medof M.E., Iida K., and Nussenzweig V. Role of the complement receptor CR1 in the processing of substrate-bound C3. Ann. NY Acad. Sci. 421 (1983) 299-306
-
(1983)
Ann. NY Acad. Sci.
, vol.421
, pp. 299-306
-
-
Medof, M.E.1
Iida, K.2
Nussenzweig, V.3
-
21
-
-
0025179976
-
Human protectin (CD59), an 18, 000-20, 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers
-
Meri S., Morgan B.P., Davies A., Daniels R.H., Olavesen M.G., Waldmann H., and Lachmann P.J. Human protectin (CD59), an 18, 000-20, 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71 (1990) 1-9
-
(1990)
Immunology
, vol.71
, pp. 1-9
-
-
Meri, S.1
Morgan, B.P.2
Davies, A.3
Daniels, R.H.4
Olavesen, M.G.5
Waldmann, H.6
Lachmann, P.J.7
-
22
-
-
0023107563
-
Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria
-
Zalman L.S., Wood L.M., Frank M.M., and Muller-Eberhard H.J. Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria. J. Exp. Med. 165 (1987) 572-577
-
(1987)
J. Exp. Med.
, vol.165
, pp. 572-577
-
-
Zalman, L.S.1
Wood, L.M.2
Frank, M.M.3
Muller-Eberhard, H.J.4
-
23
-
-
33751035523
-
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome
-
Richards A., Kathryn Liszewski M., Kavanagh D., Fang C.J., Moulton E., Fremeaux-Bacchi V., Remuzzi G., Noris M., Goodship T.H., and Atkinson J.P. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Mol. Immunol. 44 (2007) 111-122
-
(2007)
Mol. Immunol.
, vol.44
, pp. 111-122
-
-
Richards, A.1
Kathryn Liszewski, M.2
Kavanagh, D.3
Fang, C.J.4
Moulton, E.5
Fremeaux-Bacchi, V.6
Remuzzi, G.7
Noris, M.8
Goodship, T.H.9
Atkinson, J.P.10
-
24
-
-
0036097127
-
Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis
-
Lin F., Emancipator S.N., Salant D.J., and Medof M.E. Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis. Lab. Invest. 82 (2002) 563-569
-
(2002)
Lab. Invest.
, vol.82
, pp. 563-569
-
-
Lin, F.1
Emancipator, S.N.2
Salant, D.J.3
Medof, M.E.4
-
25
-
-
0036841116
-
Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection
-
Lin F., Kaminski H.J., Conti-Fine B.M., Wang W., Richmonds C., and Medof M.E. Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection. J. Clin. Invest. 110 (2002) 1269-1274
-
(2002)
J. Clin. Invest.
, vol.110
, pp. 1269-1274
-
-
Lin, F.1
Kaminski, H.J.2
Conti-Fine, B.M.3
Wang, W.4
Richmonds, C.5
Medof, M.E.6
-
26
-
-
33847220736
-
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells
-
Zheng Y., Josefowicz S.Z., Kas A., Chu T.T., Gavin M.A., and Rudensky A.Y. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445 (2007) 936-940
-
(2007)
Nature
, vol.445
, pp. 936-940
-
-
Zheng, Y.1
Josefowicz, S.Z.2
Kas, A.3
Chu, T.T.4
Gavin, M.A.5
Rudensky, A.Y.6
-
27
-
-
0033607212
-
Activation changes the spectrum but not the diversity of genes expressed by T cells
-
Teague T.K., Hildeman D., Kedl R.M., Mitchell T., Rees W., Schaefer B.C., Bender J., Kappler J., and Marrack P. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. USA 96 (1999) 12691-12696
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 12691-12696
-
-
Teague, T.K.1
Hildeman, D.2
Kedl, R.M.3
Mitchell, T.4
Rees, W.5
Schaefer, B.C.6
Bender, J.7
Kappler, J.8
Marrack, P.9
-
28
-
-
19344364971
-
Decay-accelerating factor modulates induction of T cell immunity
-
Heeger P.S., Lalli P.N., Lin F., Valujskikh A., Liu J., Muqim N., Xu Y., and Medof M.E. Decay-accelerating factor modulates induction of T cell immunity. J. Exp. Med. 201 (2005) 1523-1530
-
(2005)
J. Exp. Med.
, vol.201
, pp. 1523-1530
-
-
Heeger, P.S.1
Lalli, P.N.2
Lin, F.3
Valujskikh, A.4
Liu, J.5
Muqim, N.6
Xu, Y.7
Medof, M.E.8
-
29
-
-
0022470257
-
Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF)
-
Nicholson-Weller A., Russian D.A., and Austen K.F. Natural killer cells are deficient in the surface expression of the complement regulatory protein, decay accelerating factor (DAF). J. Immunol. 137 (1986) 1275-1279
-
(1986)
J. Immunol.
, vol.137
, pp. 1275-1279
-
-
Nicholson-Weller, A.1
Russian, D.A.2
Austen, K.F.3
-
30
-
-
0026738059
-
Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells
-
Finberg R.W., White W., and Nicholson-Weller A. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells. J. Immunol. 149 (1992) 2055-2060
-
(1992)
J. Immunol.
, vol.149
, pp. 2055-2060
-
-
Finberg, R.W.1
White, W.2
Nicholson-Weller, A.3
|